NAMSA Acquires the U.S. Medical Device Testing Operations of WuXi AppTec, Solidifying its Position as the Leader in MedTech Testing and Clinical Research

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Science
Other Science
Research
Pharmaceutical
Health
Medical Devices
Health Technology
Clinical Trials
WuXi AppTec

More Like This

PR Newswire associated0

Discover Medtecs' Latest Innovations in Medical Protection and Sustainability at MEDICA 2024

Novotech Appoints Dr. Judith Ng-Cashin as Chief Medical Officer to Drive Global Medical Services

PR Newswire associated0

Medtecs to Attend MEDICA 2023 and A+A 2023 Trade Fair in Germany and Showcase Taiwan's PPE Advantage

WuXi Biologics' Four Manufacturing Facilities and Biosafety Testing Center Certified Again by European Medicines Agency for Ten Biologics

WuXi Biologics Announces Research Service Agreement with BioNTech on Discovering Investigational Monoclonal Antibodies for Developing Next-Generation Therapeutic Product Candidates

PR Newswire associated0

medac cooperates with Scienta Lab to generate new insights in rheumatology care with AI-powered solutions

PR Newswire associated0

18 of the Top 20 Medtech Companies Partner with Veeva MedTech to Get Devices and Diagnostics to Patients Faster

PR Newswire associated0

Cambrex Announces Sale of Drug Product Business Unit